A severe hypersensitivity reaction was reported during tofersen therapy in ALS
Original source
Severe hypersensitivity reaction during tofersen therapy in amyotrophic lateral sclerosis associated with the rare SOD1 p.Val120Phe mutation. (opens in a new tab)Compass holds only the headline and link for this source, so the summary below is necessarily brief. Please read the original.
Related topics
A journal article reports a severe hypersensitivity reaction during tofersen therapy in a person with amyotrophic lateral sclerosis (ALS) and the rare SOD1 p.Val120Phe mutation.
Why this matters
This report identifies a serious reaction associated with tofersen in a person with this rare SOD1 mutation. It does not establish how often this occurs or change treatment recommendations.
Limitations and context
Only the article title and publication metadata were available. The report’s study design, number of patients, clinical details, and peer-review context beyond its journal publication could not be assessed.
Relevant to you?